GENB DCF Valuation - Generate Biomedicines Inc

Dashboard Market News Investing Ideas Pricing

G

Watchlist Manager

Watchlist

Price: 12.245 USD 2.3%

Market Cap: $1.6B

G	Generate Biomedicines Inc NASDAQ:GENB	US
A	AB Science SA F:A8D	FR
	Kakaku.com Inc TSE:2371	JP
	Renascor Resources Ltd ASX:RNU	AU
	Eurofins Scientific SE OTC:ERFSF	LU
	Mayora Indah Tbk PT OTC:PTMYF	ID
	Burford Capital Ltd F:9BFA	GG
	Maverix Metals Inc TSX:MMX	CA
N	Novo Nordisk A/S SWB:NOVA	DK
R	Redflow Ltd OTC:REFXF	AU
	Exro Technologies Inc TSX:EXRO	CA
S	Sixt SE XBER:SIX3	DE
C	Cronos Group Inc NASDAQ:CRON	CA

GENB's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.